HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-JUN-18 6DMG TITLE A MULTICONFORMER LIGAND MODEL OF EK6 BOUND TO ERK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, MULTICONFORMER MODEL, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.M.HUDSON,G.C.P.VAN ZUNDERT,D.A.KEEDY,R.FONSECA,A.HELIOU,P.SURESH, AUTHOR 2 K.BORRELLI,T.DAY,J.S.FRASER,H.VAN DEN BEDEM REVDAT 2 24-APR-19 6DMG 1 JRNL REVDAT 1 19-DEC-18 6DMG 0 JRNL AUTH G.C.P.VAN ZUNDERT,B.M.HUDSON,S.H.P.DE OLIVEIRA,D.A.KEEDY, JRNL AUTH 2 R.FONSECA,A.HELIOU,P.SURESH,K.BORRELLI,T.DAY,J.S.FRASER, JRNL AUTH 3 H.VAN DEN BEDEM JRNL TITL QFIT-LIGAND REVEALS WIDESPREAD CONFORMATIONAL HETEROGENEITY JRNL TITL 2 OF DRUG-LIKE MOLECULES IN X-RAY ELECTRON DENSITY MAPS. JRNL REF J. MED. CHEM. V. 61 11183 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30457858 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01292 REMARK 0 REMARK 0 THIS ENTRY 6DMG REFLECTS AN ALTERNATIVE MODELING OF THE REMARK 0 ORIGINAL DATA IN 4FV3, DETERMINED BY Y.N.KANG,J.A.STUCKEY,X.XIE REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11_2558 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 19363 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.9307 - 4.2057 0.94 2591 125 0.1663 0.1830 REMARK 3 2 4.2057 - 3.3395 0.99 2640 148 0.1688 0.2156 REMARK 3 3 3.3395 - 2.9177 0.99 2666 139 0.1954 0.2835 REMARK 3 4 2.9177 - 2.6511 0.99 2630 156 0.1975 0.2504 REMARK 3 5 2.6511 - 2.4612 0.99 2649 146 0.2089 0.2694 REMARK 3 6 2.4612 - 2.3161 0.98 2618 147 0.2115 0.2872 REMARK 3 7 2.3161 - 2.2002 0.97 2579 129 0.2310 0.2684 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2992 REMARK 3 ANGLE : 0.505 4061 REMARK 3 CHIRALITY : 0.041 437 REMARK 3 PLANARITY : 0.003 515 REMARK 3 DIHEDRAL : 13.236 1769 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DMG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000234810. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19388 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 120.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 1.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: AUTHOR USED THE SF DATA FROM ENTRY 4FV3 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES BUFFER, PH 6.5, 26-28% PEG REMARK 280 -MME 2000, 200 MM AMMONIUM SULFATE AND 20 MM 2-MERCAPTOETHANOL, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.35000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 10 CG CD OE1 OE2 REMARK 470 GLN A 64 CG CD OE1 NE2 REMARK 470 ARG A 275 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 328 CG CD CE NZ REMARK 470 ASP A 330 CG OD1 OD2 REMARK 470 MET A 331 CG SD CE REMARK 470 GLU A 332 CG CD OE1 OE2 REMARK 470 ASP A 335 CG OD1 OD2 REMARK 470 LYS A 338 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH TYR A 314 O HOH A 508 1.58 REMARK 500 O3 SO4 A 402 O HOH A 501 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 29 -68.31 -126.24 REMARK 500 TYR A 34 28.87 -156.89 REMARK 500 ASP A 147 35.04 -150.49 REMARK 500 ASP A 165 88.76 60.69 REMARK 500 ASP A 173 66.53 -153.67 REMARK 500 ASN A 199 25.72 -165.37 REMARK 500 LEU A 292 46.18 -98.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EK6 A 407 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4FV3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK6 DBREF 6DMG A 9 355 UNP P28482 MK01_HUMAN 11 357 SEQRES 1 A 347 PRO GLU MET VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO SEQRES 2 A 347 ARG TYR THR ASN LEU SER TYR ILE GLY GLU GLY ALA TYR SEQRES 3 A 347 GLY MET VAL CYS SER ALA TYR ASP ASN VAL ASN LYS VAL SEQRES 4 A 347 ARG VAL ALA ILE LYS LYS ILE SER PRO PHE GLU HIS GLN SEQRES 5 A 347 THR TYR CYS GLN ARG THR LEU ARG GLU ILE LYS ILE LEU SEQRES 6 A 347 LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP SEQRES 7 A 347 ILE ILE ARG ALA PRO THR ILE GLU GLN MET LYS ASP VAL SEQRES 8 A 347 TYR ILE VAL GLN ASP LEU MET GLU THR ASP LEU TYR LYS SEQRES 9 A 347 LEU LEU LYS THR GLN HIS LEU SER ASN ASP HIS ILE CYS SEQRES 10 A 347 TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE SEQRES 11 A 347 HIS SER ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SER SEQRES 12 A 347 ASN LEU LEU LEU ASN THR THR CME ASP LEU LYS ILE CYS SEQRES 13 A 347 ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP SEQRES 14 A 347 HIS THR GLY PHE LEU THR GLU TYR VAL ALA THR ARG TRP SEQRES 15 A 347 TYR ARG ALA PRO GLU ILE MET LEU ASN SER LYS GLY TYR SEQRES 16 A 347 THR LYS SER ILE ASP ILE TRP SER VAL GLY CYS ILE LEU SEQRES 17 A 347 ALA GLU MET LEU SER ASN ARG PRO ILE PHE PRO GLY LYS SEQRES 18 A 347 HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU SEQRES 19 A 347 GLY SER PRO SER GLN GLU ASP LEU ASN CYS ILE ILE ASN SEQRES 20 A 347 LEU LYS ALA ARG ASN TYR LEU LEU SER LEU PRO HIS LYS SEQRES 21 A 347 ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SEQRES 22 A 347 SER LYS ALA LEU ASP LEU LEU ASP LYS MET LEU THR PHE SEQRES 23 A 347 ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA SEQRES 24 A 347 HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SER ASP GLU SEQRES 25 A 347 PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP MET GLU LEU SEQRES 26 A 347 ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE SEQRES 27 A 347 GLU GLU THR ALA ARG PHE GLN PRO GLY MODRES 6DMG CME A 159 CYS MODIFIED RESIDUE HET CME A 159 18 HET SO4 A 401 5 HET SO4 A 402 5 HET SO4 A 403 5 HET EDO A 404 10 HET EDO A 405 10 HET EDO A 406 10 HET EK6 A 407 130 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM EK6 ETHYL N-{2-CHLORO-4-[5-(5-{[(1S)-1-(3-CHLORO-4- HETNAM 2 EK6 FLUOROPHENYL)-2-HYDROXYETHYL]CARBAMOYL}-1H-PYRROL-3- HETNAM 3 EK6 YL)-1H-PYRAZOL-4-YL]BENZYL}GLYCINATE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 SO4 3(O4 S 2-) FORMUL 5 EDO 3(C2 H6 O2) FORMUL 8 EK6 C27 H26 CL2 F N5 O4 FORMUL 9 HOH *170(H2 O) HELIX 1 AA1 HIS A 59 PHE A 76 1 18 HELIX 2 AA2 LEU A 110 GLN A 117 1 8 HELIX 3 AA3 SER A 120 ALA A 141 1 22 HELIX 4 AA4 LYS A 149 SER A 151 5 3 HELIX 5 AA5 ASP A 173 ASP A 177 5 5 HELIX 6 AA6 THR A 188 ARG A 192 5 5 HELIX 7 AA7 ALA A 193 MET A 197 5 5 HELIX 8 AA8 LYS A 205 ASN A 222 1 18 HELIX 9 AA9 HIS A 230 GLY A 243 1 14 HELIX 10 AB1 SER A 246 CYS A 252 1 7 HELIX 11 AB2 ASN A 255 LEU A 265 1 11 HELIX 12 AB3 PRO A 272 PHE A 277 1 6 HELIX 13 AB4 ASP A 281 LEU A 292 1 12 HELIX 14 AB5 GLU A 301 ALA A 307 1 7 HELIX 15 AB6 HIS A 308 GLU A 312 5 5 HELIX 16 AB7 ASP A 316 GLU A 320 5 5 HELIX 17 AB8 PRO A 337 THR A 349 1 13 HELIX 18 AB9 ALA A 350 GLN A 353 5 4 SHEET 1 AA1 5 TYR A 23 GLU A 31 0 SHEET 2 AA1 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24 SHEET 3 AA1 5 VAL A 47 ILE A 54 -1 O LYS A 53 N MET A 36 SHEET 4 AA1 5 VAL A 99 GLN A 103 -1 O GLN A 103 N ALA A 50 SHEET 5 AA1 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 AA2 3 THR A 108 ASP A 109 0 SHEET 2 AA2 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 AA2 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 AA3 2 VAL A 143 LEU A 144 0 SHEET 2 AA3 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 LINK C THR A 158 N CME A 159 1555 1555 1.34 LINK C CME A 159 N ASP A 160 1555 1555 1.38 CISPEP 1 GLY A 20 PRO A 21 0 0.94 SITE 1 AC1 6 TYR A 185 ARG A 189 ARG A 192 TYR A 231 SITE 2 AC1 6 HOH A 504 HOH A 512 SITE 1 AC2 3 LYS A 205 GLU A 301 HOH A 501 SITE 1 AC3 1 ARG A 189 SITE 1 AC4 3 SER A 151 THR A 188 EK6 A 407 SITE 1 AC5 1 TYR A 314 SITE 1 AC6 4 LEU A 114 LYS A 115 THR A 116 HIS A 118 SITE 1 AC7 23 ILE A 29 GLY A 30 GLU A 31 GLY A 32 SITE 2 AC7 23 GLY A 35 VAL A 37 ALA A 50 LYS A 52 SITE 3 AC7 23 ILE A 82 GLN A 103 ASP A 104 LEU A 105 SITE 4 AC7 23 MET A 106 SER A 151 ASN A 152 LEU A 154 SITE 5 AC7 23 CYS A 164 ASP A 165 EDO A 404 HOH A 507 SITE 6 AC7 23 HOH A 513 HOH A 532 HOH A 546 CRYST1 48.780 70.700 60.860 90.00 110.11 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020500 0.000000 0.007506 0.00000 SCALE2 0.000000 0.014144 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017498 0.00000